Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2014, Article ID 980301, 10 pages
http://dx.doi.org/10.1155/2014/980301
Review Article

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

1National Research Center, Tahrir Street, Cairo, Egypt
2Adult HSCT Program, Ain Shams University Hospitals, P.O. Box 1156, Cairo, Egypt
3Adult HSCT Program, Oncology Center, King Faisal Specialist Hospital & Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia
4Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Center, P.O. BOX 3354, Riyadh 11211, Saudi Arabia

Received 17 July 2014; Revised 22 September 2014; Accepted 23 September 2014; Published 27 October 2014

Academic Editor: Diego Cantarovich

Copyright © 2014 Amr Nassar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Amr Nassar, Ghada Elgohary, Tusneem Elhassan, Zubeir Nurgat, Said Y. Mohamed, and Mahmoud Aljurf, “Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation,” Journal of Transplantation, vol. 2014, Article ID 980301, 10 pages, 2014. https://doi.org/10.1155/2014/980301.